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ABSTRACT
Introduction: The ectopic fat accumulation in the liver, known as nonalcoholic fatty liver disease (NAFLD), 
is associated with insulin resistance, dyslipidemia, and high risk of diabetes and cardiovascular diseases. 
Nonalcoholic fatty pancreas disease (NAFPD) is defined as obesity-associated accumulation of fat in the 
pancreas without signs of secondary causes of steatosis. The pathophysiology of NAFPD and NAFLD is 
closely related. But the causal relationship between NAFLD and NAFPD has not  been well established yet.
The aim of the study is to investigate the relationship between liver and pancreatic steatosis (PS); to establish 
the influence of the PS on the structural changes of the liver and pancreas.
Materials and Methods: A total of 117 children aged 6-17 years (mean 11.67 ± 2.81 years; 68 boys, 49 
girls) were included. Patients were divided into 5 groups: group 1 - 37 children with combined liver and 
pancreatic steatosis, 2 group - 30 children with isolated steatosis of the pancreas, 3 group - 6 children with 
isolated liver steatosis, 4 group - 28 children with obesity / overweight without liver and pancreatic steatosis, 
5 group - 16 children with normal weight. Pancreatic steatosis was established on the basis of ultrasound 
examination of the pancreas. Diagnosis of non-alcoholic fatty liver disease was established in the presence 
of signs of liver steatosis according to transient elastography with CAP function (Fibroscan 502 Touch). 
We also performed a quantitative estimation of the ultrasound attenuation coefficient (UAC) conducted on 
UltimaPAExpert apparatus ("Radmir", Ukraine). To determine the stiffness of the pancreatic parenchyma, 
shear wave elastography using UltimaPAExpert (Radmir, Ukraine) was performed.
Results: It was found that children with combined steatosis showed higher levels of UAC and CAP compared 
to children with normal weight (p<0,05). The maximum degree of liver steatosis according to the CAP was 
observed in the group with combined steatosis (p<0.05). It should be noted that children with combined 
liver steatosis had higher liver and pancreatic stiffness values in comparison with children having isolated 
pancreatic steatosis (p<0,05). This fact can be explained by more intensive fibrotic changes in the liver 
and pancreas in case of combined steatosis but also inflammatory changes in this organs can influence on 
stiffness parameters. In the correlation analysis, there was a positive correlation between UAC and СAP. 
Also we found positive correlation between pancreatic and liver stiffness according to SWE.
Conclusion: Our findings along with literature data show that pancreatic steatosis precedes the appearance 
of liver steatosis. We assume that pancreatic steatosis as well as liver steatosis is accompanied with rise of 
parenchyma stiffness of these organs. Patients who had signs of liver steatosis and pancreatic steatosis had 
the most adverse structural changes in the form of increased stiffness of the parenchyma of the liver and 
pancreas.
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Introduction
The pancreatic steatosis was first described in 1933, but this 
problem is given increasing attention in the last five years, which 
can be explained by the growing epidemic of obesity and its 
complications [1]. Nonalcoholic fatty pancreas disease (NAFPD) 
is defined as obesity-related accumulation of fat in the pancreas 
without signs of secondary causes of steatosis [2]. In humans, 
NAFPD is closely associated with increasing body mass index 
(BMI), visceral fat, insulin resistance and metabolic syndrome 
[3,4].
The type of adipose tissue distribution is an important factor in 
predicting obesity-related metabolic disorders [5]. The ectopic 
accumulation of fat in the liver, known as nonalcoholic fatty liver 
disease (NAFLD), is closely related with NAFPD pathophysiology. 
But the causal relationship between NAFLD and NAFPD has not 
been well established yet. Further researches are needed to study 
the effects of NAFPD on the course of NAFLD.
The aim is to investigate the relationship between liver and 
pancreatic steatosis (PS); to establish the influence of the PS on 
the structural changes of the liver and pancreas.
Materials and Methods
A total of 117 children aged 6-17 years (mean 11.67 ± 2.81 
years; 68 boys, 49 girls) were included in the study. This study 
was conducted on the basis of the State Institution "Institute of 
Gastroenterology of the National Academy of Medical Sciences 
of Ukraine" during two years: 2016-2017. The inclusion criteria 
for the study was the presence of overweight and obesity. The 
exclusion criteria were: acute and chronic liver disease, acute and 
chronic pancreatitis, history of taking toxic drugs, type 1 diabetes 
and type 2 diabetes. Patients were divided into 5 groups: group 
1-37 children with combined liver and pancreatic steatosis, 2 
group - 30 children with isolated pancreatic steatosis, 3 group - 6 
children with isolated liver steatosis, 4 group - 28 children with 
obesity / overweight without liver and pancreatic steatosis, 5 group 
- 16 children with normal weight. Groups were homogeneous in 
regards to age and gender.
Pancreatic steatosis was established on the basis of ultrasound 
examination of the pancreas using an ultrasound scanner "Toshiba 
Xario SSA660-A" (Japan). Diagnosis of non-alcoholic fatty liver 
disease was established in the presence of signs of liver steatosis 
according to transient elastography with CAP function (Fibroscan 
502 Touch) in children with obesity/overweight in the exclusion of 
other secondary steatosis.
In order to diagnose pancreatic steatosis, a steatometry of the 
pancreas was also performed - a quantitative estimation of 
the ultrasound attenuation coefficient (UAC) conducted on 
UltimaPAExpert apparatus ("Radmir", Ukraine). To determine the 
stiffness of the pancreatic parenchyma, shear wave elastography 
using UltimaPAExpert (Radmir, Ukraine) was performed.
Methods of nonparametric statistics were used - when indicating 
quantitative characteristics, data were presented as median and 
interquartile intervals [25; 75%], for qualitative signs - in the 
form of relative indicators - n (%). For comparing group data, the 
Kruskel-Wallis criterion was used. When comparing qualitative 
indicators, the assessment of the differences was carried out 
according to Fisher's exact criterion. Correlation analysis was 
carried out with the calculation of the rank correlation coefficient 
Spearmen - R. Two-tailed p<0.05 indicated statistical significance. 
Statistical analyses were performed by using the Statistica 7.0.
Results
Among the studied 117 patients, 67 (57.3%) had signs of pancreatic 
steatosis, 43 patients (36.7%) – of liver steatosis. Among patients 
with obesity / overweight, the incidence of pancreatic steatosis 
was 1.5 times higher than diagnosed liver steatosis. Among 
patients with pancreatic steatosis in more than half of patients liver 
steatosis was detected, while in patients with liver steatosis more 
than 80% of patients were found PS.
It was found that children with combined steatosis showed higher 
levels of UAC and CAP compared to children with normal 
weight (p<0,05) (Table 1). The maximum degree of liver steatosis 
according to the CAP was observed in the group with combined 
steatosis (p<0.05) (Tab 1). It should be noted that children with 
combined liver steatosis had higher liver and pancreatic stiffness 
values in comparison with children having isolated pancreatic 
steatosis (p<0,05) (Figures 1 and 2). This fact can be explained by 
more intensive fibrotic changes in the liver and pancreas in case of 
combined steatosis but also inflammatory changes in this organs 
can influence on stiffness parameters.
Figure 1: Liver stiffness distribution according to groups.
In the correlation analysis, there was a positive correlation between 
UAC and СAP (Figure 3). Also we found positive correlation 
between pancreatic and liver stiffness according to SWE (Figure 
4).
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Figure 2: Pancreatic stiffness distribution according to groups.
Figure 3: Correlation between CAP and UAC.
Figure 4: Correlation between liver and pancreatic stiffness.
Thus, more than half of patients with pancreatic steatosis had 
associated liver steatosis. Patients who had signs of liver steatosis 
and pancreatic steatosis had the most adverse structural changes 
in the form of increased liver and pancreas parenchyma stiffness. 
The obtained data testify to the necessity of early diagnosis of liver 
and pancreatic steatosis, and a differentiated approach depending 
on their coexistence.
Discussion
As we know, this is the first study on structural changes in the 
liver and pancreas, depending on the coexistence of steatosis with 
the determination of the attenuation of ultrasound and parenchyma 
stiffness.
Morphological peculiarity of pancreatic steatosis in contrast to 
liver steatosis characterized mainly by intracellular fatty infiltration 
is an increase in adipocyte content - extracellular accumulation of 
lipids, although intracellular accumulation may also occur [1].
Many studies show evidence of a close connection between liver 
and pancreatic steatosis, and fatty infiltration of the pancreas is 
considered as a process preceding liver steatosis. So, in the study 
of autopsy material, Erwin-Jan van Geenen et al. have shown that 
the total content of adipose tissue positively correlates with the 
presence of NAFLD. In 68% of cases pancreatic steatosis was 
accompanied by steatosis of the liver, most subjects (97%) with 
steatosis of the liver also had pancreatic steatosis [6]. Our study 
confirmed this data, so more than half of patients with NAFPD had 
NAFLD and 80% with NAFLD had signs of NAFPD.
According to P. Sepe et al. (2009) [7], P. E. Sijens et al. (2010) [8] 
the content of fatty pancreatic tissue was elevated in patients with 
high NAFLD activity according to the morphological study of the 
liver. The authors found that the total content of adipose tissue 
in the pancreas was reduced in patients with NAFLD with severe 
fibrosis of the liver, decreased degree of liver steatosis in these 
patients is likely to be related to the development of fibrosis.
In our study children with combined steatosis had higher level 
of pancreatic and liver stiffness, these parameters positively 
correlated between each other.
In own study E. Aleshina et al. shows that sonographic signs 
of pancreatic steatosis are observed in 70% of children with 
overweight and preceded by the discovery of signs of liver 
steatosis [9]. In M. Cohen et al. [10] showed that in children and 
adolescents, the fat content of the pancreas determined by MRI, 
correlated with the content of fatty tissue in the liver and visceral 
Characteristic 1 group 2 group 3 group 4 group 5 group
UAC, dB/sm 2,50 [2,32; 2,70] #* 2,6 [2,34; 2,75] *# 2,28 [2,14; 2,95] 2,15 [1,93; 2,41] 1,87 [1,75; 2,15]
Pancreatic stiffness, кPа 3,80 [3,38; 4,27] ^ 3,39 [2,90; 3,87] 3,16 [2,59; 3,53] 3,51 [3,21; 3,77]   3,56 [3,28; 3,83]
CAP, дB/m 261,0 [240,0; 282,0] *# ** 206,5 [193,0; 228,0] #* 260,5 [249,0; 275,0] *# 195,0 [171,0; 209,0] 164,0 [116.5; 196.5]
Liver stiffness, кPа 4,3 [3,8; 4,8] ^ 3,6 [3,4; 4,10] 4,3 [3,7; 4,7] 3,8 [3,2; 4,7] 3,95 [3,64; 4,4]
Table 1: Sonological characteristics of the patients. Note. * - p1 <0,05 compared with the 4 group; # - p1 <0,05 compared with 5 group; ^ - p <0,05 
compared with group 2.
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fat. However, after adjusting for gender, ethnicity and puberty, 
the fat content of the PS was associated only with visceral fat. In 
contrast to this study, C. M. Toledo-Corral et al. [11] demonstrated 
that adolescents with pre-diabetes have a higher level of fat content 
in the liver and pancreas compared with control group, regardless 
of general and visceral obesity.
It is likely that the results of the above-mentioned works are 
contradictory due to the use of various methods for diagnosis of 
steatosis. We demonstrated that prevalence of fatty pancreas was 
66.3% in obese/overweight children. Epidemiological studies 
showed a high incidence of fatty pancreas in population [12], but 
these data have rarely included population from Europe; therefore, 
more studies should be provided in this direction. We think that 
there is need for more research in obesity-related mechanisms 
of pancreatic and liver injury, the role of the non-alcoholic fatty 
pancreatic disease, and the underlying mechanisms associating 
obesity [13].
Conclusions
Our findings along with literature data show that pancreatic steatosis 
precedes the appearance of liver steatosis. Isolated liver steatosis 
can be explained by insufficient sensitivity of standard ultrasound 
study in diagnosis of pancreatic steatosis while liver steatosis was 
diagnosed with more sensitive method (transient electrography 
with CAP function). Also we suppose that genetic features of 
visceral fat distribution exist. We assume that pancreatic steatosis 
as well as liver steatosis is accompanied with rise of parenchyma 
stiffness of these organs.
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